Rubicon Laboratory, Inc.

Baltimore, MD 21204

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $315K
First Award Date 06/01/98
Most Recent Award Date 01/26/04

Key Personnel

Last Name Name Awards Contact
Lauermann Vit Lauermann 4

4 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-03-21
Budget: 01/26/04 - 10/31/05

DESCRIPTION (provided by applicant): The goal of this project is to develop novel therapy for prostate cancer. We propose to develop novel antibody-based therapeutics with high specificity for a target tumor cell. The tumor-selective antibody approach can be adapted for many antibodies and tumor types. Treatment of many solid tumors with antibod...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-01-52
Budget: 05/01/03 - 10/31/04

DESCRIPTION (provided by applicant): The overall goal of this project is to develop a therapeutic method for targeted delivery of IL-4 to arthritic joints. Rheumatoid arthritis is an autoimmune disease characterized by progressive cartilage and bone erosion. Cytokines are important modulators of immune responses and IL-4 is an attractive cytokin...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/98 - 09/30/99

Our initial goal is to construct and characterize a novel hybrid retrovirus efficiently expressing and utilizing a human virus envelope. Vectors we will develop based on this construct will be the first retroviral vectors capable of effective, safe and repeated genetic transfer into the human...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/98 - 05/31/99

The aim of this project is to construct and characterize a new type of hybrid retrovirus that will use a novel replication strategy. This replication strategy will make the virus safer for use, either as a therapeutic or a preventive tool. It is the specific aim of this project to engineer thi...